Guía detallada disponible en inglés. MFMD ofrece orientación y coordinación del centro en español.
Yes, hormone-pellet therapy can be part of a properly structured medical practice, but “pellets” are not one uniform product category. Distinguish FDA-approved products from compounded pellet preparations, and define the procedural, prescribing, sourcing, documentation, aftercare, and complication-management workflow before launch.
Abrir la explicación completa3 secciones y fuentes primarias
Does it matter which hormone pellet product the clinic uses?
TESTOPEL is a marketed prescription testosterone pellet product listed as Schedule III. Compounded hormone pellets are a separate product pathway and should not be presented as equivalent merely because both are implanted. Confirm the exact product.
What procedure questions apply to pellet insertion?
Who prescribes, and who performs insertion — is the procedure within that practitioner’s scope? What training/competency is required? How are sterile technique and supplies handled? What aftercare is provided, what is the escalation pathway for infection, extrusion, or bleeding, and how is informed consent documented?
Owner takeaway
Adding pellets means adding both a medication service and an office procedure. Build both sides — product/sourcing and procedure/aftercare — before launch.